Biogen (BIIB) PT Lowered to $382 at SVB Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cowen Downgrades Biogen (BIIB) to Market Perform
November 9, 2020 6:18 AM ESTCowen analyst Phil Nadeau downgraded Biogen (NASDAQ: BIIB) from Outperform to Market Perform with a price target of $215.00 (from $275.00).
The analyst comments "The PCNSDAC's votes were a resounding and near unanimous rebuke of aducanumab, BIIB and the FDA. As FDA approval of... More
